Understanding neuropathic pain presents several challenges, given the various mechanisms underlying its pathophysiological classification and the lack of suitable tools to assess its di-agnosis. Furthermore, the response of this pathology to available drugs is still often unpredictable, leaving the treatment of neuropathic pain still questionable. In addition, the rise of personalized treatments further extends the ramified classification of neuropathic pain. While a few authors have focused on neuropathic pain clustering, by analyzing, for example, the presence of specific TRP channels, others have evaluated the presence of alterations in microRNAs to find tailored therapies. Thus, this review aims to synthesize the available evidence on the topic from a clinical perspective and provide a list of current demonstrations on the treatment of this disease.
CITATION STYLE
Balzani, E., Fanelli, A., Malafoglia, V., Tenti, M., Ilari, S., Corraro, A., … Raffaeli, W. (2021, September 1). A review of the clinical and therapeutic implications of neuropathic pain. Biomedicines. MDPI. https://doi.org/10.3390/biomedicines9091239
Mendeley helps you to discover research relevant for your work.